These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 23769438

  • 1. [Significance of carbonic anhydrase IX protein expression in molecular subtyping of breast cancers].
    Li MP, Ren LF, Cai HG, Yang HY, Lu B, Zhang P, Bao L.
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):182-5. PubMed ID: 23769438
    [Abstract] [Full Text] [Related]

  • 2. [Significance of carbonic anhydrase IX protein in fibrotic foci of mammary invasive ductal carcinomas].
    Li M, Bao L, Cai H, Yang H, Ge W, Ren L, Lu B.
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):250-3. PubMed ID: 25975907
    [Abstract] [Full Text] [Related]

  • 3. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F, Simionescu C, Georgescu CV, Pirici E.
    Rom J Morphol Embryol; 2011 Apr; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
    Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL.
    J Clin Oncol; 2001 Aug 15; 19(16):3660-8. PubMed ID: 11504747
    [Abstract] [Full Text] [Related]

  • 5. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouysségur J, Berra E.
    Int J Cancer; 2007 Apr 01; 120(7):1451-8. PubMed ID: 17245699
    [Abstract] [Full Text] [Related]

  • 6. [Expression of carbonic anhydrase IX in the breast carcinomas].
    Kajo K, Turčan I, Vallová M, Laboš T, Kajo M, Macháleková K, S G, Zúbor P.
    Ceska Gynekol; 2013 Jun 01; 78(3):263-8. PubMed ID: 23869833
    [Abstract] [Full Text] [Related]

  • 7. [Relationship between breast cancer molecular subtypes with clinicopathological characteristics and prognosis].
    Lin M, Chen ZQ, Bao Y, Li Q, Du ZG, Xu ZD, Tang F.
    Zhonghua Bing Li Xue Za Zhi; 2010 Jun 01; 39(6):372-6. PubMed ID: 21055152
    [Abstract] [Full Text] [Related]

  • 8. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
    Choi J, Jung WH, Koo JS.
    Pathobiology; 2013 Jun 01; 80(1):41-52. PubMed ID: 22832328
    [Abstract] [Full Text] [Related]

  • 9. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
    Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA.
    Breast Cancer Res Treat; 2003 Sep 01; 81(2):137-47. PubMed ID: 14572156
    [Abstract] [Full Text] [Related]

  • 10. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J, Liu XL, Han LZ, Xiao G, Li NL, Deng YN, Yin LC, Ling LJ, Yu XY, Tan CL, Huang XP, Liu LX.
    Asian Pac J Cancer Prev; 2015 Sep 01; 16(2):823-9. PubMed ID: 25684532
    [Abstract] [Full Text] [Related]

  • 11. Breast cancer subtypes identified by the ER, PR and HER-2 status in Thai women.
    Chuthapisith S, Permsapaya W, Warnnissorn M, Akewanlop C, Sirivatanauksorn V, Prasarttong Osoth P.
    Asian Pac J Cancer Prev; 2012 Sep 01; 13(2):459-62. PubMed ID: 22524806
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients.
    Kaya AO, Gunel N, Benekli M, Akyurek N, Buyukberber S, Tatli H, Coskun U, Yildiz R, Yaman E, Ozturk B.
    J BUON; 2012 Sep 01; 17(4):663-8. PubMed ID: 23335522
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy].
    Zheng S, Zhang BL, Xiao T, Zou SM, Xue LY, Luo W, Guo L, Liu XY, Lü N.
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul 01; 40(7):465-70. PubMed ID: 22088373
    [Abstract] [Full Text] [Related]

  • 14. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y.
    Jpn J Clin Oncol; 2012 May 01; 42(5):375-86. PubMed ID: 22450930
    [Abstract] [Full Text] [Related]

  • 15. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
    Sánchez-Muñoz A, Román-Jobacho A, Pérez-Villa L, Sánchez-Rovira P, Miramón J, Pérez D, Sáez MI, de Luque V, Medina L, Ramírez-Tortosa CL, Vicioso L, Medina JA, Ribelles N, Alba E.
    Oncology; 2012 May 01; 83(4):228-33. PubMed ID: 22907070
    [Abstract] [Full Text] [Related]

  • 16. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.
    Fernandes RC, Bevilacqua JL, Soares IC, Siqueira SA, Pires L, Hegg R, Carvalho FM.
    Histopathology; 2009 Sep 01; 55(3):346-52. PubMed ID: 19723150
    [Abstract] [Full Text] [Related]

  • 17. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
    Liu H, Fan QH, Zhang ZH, Li X, Yu HP, Liu GZ, Meng FQ.
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan 01; 38(1):23-8. PubMed ID: 19489221
    [Abstract] [Full Text] [Related]

  • 18. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
    Wang Y, Yin Q, Yu Q, Zhang J, Liu Z, Wang S, Lv S, Niu Y.
    Breast Cancer Res Treat; 2011 Nov 01; 130(2):489-98. PubMed ID: 21837481
    [Abstract] [Full Text] [Related]

  • 19. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
    Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Govender D, Kibera J, Carrara H, Saleh M.
    Breast; 2014 Oct 01; 23(5):591-6. PubMed ID: 25012047
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R, Potemski P, Jesionek-Kupnicka D, Kordek R.
    Pol J Pathol; 2005 Oct 01; 56(3):107-10. PubMed ID: 16334976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.